Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study

Nicola Potere; Marcello di Nisio; Donatella Cibelli; Rosa Scurti; Antonella Frattari; Ettore Porreca; Antonio Abbate; Giustino Parruti

doi:10.1136/annrheumdis-2020-218243

Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study

Nicola Potere, Marcello di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

44 Citations (Scopus)

Original language	English
Article number	annrheumdis-2020-218243
Pages (from-to)	271-272
Number of pages	2
Journal	Annals of the rheumatic diseases
Volume	80
Issue number	2
Early online date	2020
DOIs	https://doi.org/10.1136/annrheumdis-2020-218243
Publication status	Published - 1 Feb 2021
Externally published	Yes

Keywords

biological therapy
cytokines
immune system diseases
inflammation

Access to Document

10.1136/annrheumdis-2020-218243

Cite this

Potere, N., di Nisio, M., Cibelli, D., Scurti, R., Frattari, A., Porreca, E., Abbate, A., & Parruti, G. (2021). Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study. Annals of the rheumatic diseases, 80(2), 271-272. Article annrheumdis-2020-218243. https://doi.org/10.1136/annrheumdis-2020-218243

@article{808f7e2085394ba8bd8d0567f3340f3c,

title = "Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study",

keywords = "biological therapy, cytokines, immune system diseases, inflammation",

author = "Nicola Potere and {di Nisio}, Marcello and Donatella Cibelli and Rosa Scurti and Antonella Frattari and Ettore Porreca and Antonio Abbate and Giustino Parruti",

year = "2021",

month = feb,

day = "1",

doi = "10.1136/annrheumdis-2020-218243",

language = "English",

volume = "80",

pages = "271--272",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "2",

}

Potere, N, di Nisio, M, Cibelli, D, Scurti, R, Frattari, A, Porreca, E, Abbate, A & Parruti, G 2021, 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study', Annals of the rheumatic diseases, vol. 80, no. 2, annrheumdis-2020-218243, pp. 271-272. https://doi.org/10.1136/annrheumdis-2020-218243

Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study. / Potere, Nicola; di Nisio, Marcello; Cibelli, Donatella et al.
In: Annals of the rheumatic diseases, Vol. 80, No. 2, annrheumdis-2020-218243, 01.02.2021, p. 271-272.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study

AU - Potere, Nicola

AU - di Nisio, Marcello

AU - Cibelli, Donatella

AU - Scurti, Rosa

AU - Frattari, Antonella

AU - Porreca, Ettore

AU - Abbate, Antonio

AU - Parruti, Giustino

PY - 2021/2/1

Y1 - 2021/2/1

KW - biological therapy

KW - cytokines

KW - immune system diseases

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=85087855616&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2020-218243

DO - 10.1136/annrheumdis-2020-218243

M3 - Letter

C2 - 32647027

SN - 0003-4967

VL - 80

SP - 271

EP - 272

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 2

M1 - annrheumdis-2020-218243

ER -

Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: A case-control study

Keywords

Access to Document

Other files and links

Cite this